Effects of the contraceptive patch and the vaginal ring on bone metabolism and bone mineral density: a prospective, controlled, randomized study

Contraception

Volumn 81, Issue 3, 2010, Pages 209-214

  Massaro, Mariangela ^a   Di Carlo, Costantino ^a   Gargano, Virginia ^a   Formisano, Carmen ^a   Bifulco, Giuseppe ^a   Nappi, Carmine ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Bone metabolism; Contraceptive patch; Vaginal ring

Indexed keywords

CALCIUM; DEOXYPYRIDINOLINE; ETHINYLESTRADIOL PLUS ETONOGESTREL; ETHINYLESTRADIOL PLUS NORELGESTROMIN; OSTEOCALCIN; PYRIDINOLINE;

ADULT; ARTICLE; BONE DENSITY; BONE METABOLISM; BONE TURNOVER; CALCIUM BLOOD LEVEL; CALCIUM URINE LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTRACEPTIVE PATCH; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HORMONAL CONTRACEPTION; HUMAN; LUMBAR SPINE; PROSPECTIVE STUDY; PROTEIN URINE LEVEL; RANDOMIZED CONTROLLED TRIAL; TRANSDERMAL PATCH; URINALYSIS; VAGINA RING;

ABSORPTIOMETRY, PHOTON; AMINO ACIDS; ANALYSIS OF VARIANCE; BONE AND BONES; BONE DENSITY; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVE DEVICES, FEMALE; DESOGESTREL; ESTROGENS; ETHINYL ESTRADIOL; FEMALE; HUMANS; NORGESTREL; OXIMES; PROSPECTIVE STUDIES;

EID: 76049086833     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2009.09.011     Document Type: Article

References (25)

1. Fleischer K., van Vliet H.A., Rosendaal F.R., Rosing J., Tchaikovski S., and Helmerhorst F.M. Effects of the contraceptive patch, the vaginal ring and an oral contraceptive on APC resistance and SHBG: a cross-over study. Thromb Res 123 (2008) 429-435
2. Burkman R.T. The transdermal contraceptive system. Am J Obstet Gynecol 190 4 Suppl (2004) S49-S53
3. Roumen F.J. Review of the combined contraceptive vaginal ring, NuvaRing®. Ther Clin Risk Manag 4 (2008) 441-451
4. Kuohung W., Borgatta L., and Stubblefield P. Low-dose oral contraceptives and bone mineral density: an evidence-based analysis. Contraception 61 (2000) 77-82
5. Nappi C., Di Spiezio Sardo A., Acunzo G., et al. Effects of a low-dose and ultra-low-dose combined oral contraceptive use on bone turnover and bone mineral density in young fertile women: a prospective controlled randomized study. Contraception 67 (2003) 355-359
6. Mais V., Fruzzetti F., Ajossa S., Paoletti A.M., Guerriero S., and Melis G.B. Bone metabolism in young women taking a monophasic pill containing 20 μg ethinylestradiol: a prospective study. Contraception 48 (1993) 445-452
7. Gargano V., Massaro M., Morra I., Formisano C., Di Carlo C., and Nappi C. Effects of two low-dose combined oral contraceptives containing drospirenone on bone turnover and bone mineral density in young fertile women: a prospective controlled randomized study. Contraception 78 (2008) 10-15
8. Nappi C., Di Spiezio Sardo A., Greco E., et al. Effects of an oral contraceptive containing drospirenone on bone turnover and bone mineral density. Obstet Gynecol 105 (2005) 53-60
9. Robin S.P. Biochemical markers of bone metabolism. CPD Bull Clin Biochem 1 (1999) 116-121
10. Delmas P.D. Biochemical markers of bone turnover for the clinical assessment of metabolic bone disease. Endocrinol Metab Clin North Am 19 (1990) 1-18
11. Del Puente A., Heyse S.P., Mandes M.G., et al. Epidemiology of osteoporosis in women in southern Italy. Aging (Milano) 10 (1998) 53-58
12. Recker R.R., Davies K.M., Hinders S.M., Heaney R.P., Stegman M.R., and Kimmel D.B. Bone gain in young adult women. JAMA 268 (1992) 2403-2408
13. Shargil A.A. Hormone replacement therapy in perimenopausal women with a triphasic contraceptive compound: a three year prospective study. Int J Fertil 30 (1985) 18-28
14. Lindsay R., Tohme J., and Kanders B. The effect of oral contraceptive use on vertebral bone mass in pre- and postmenopausal women. Contraception 34 (1986) 333-340
15. Kleerekoper M., Brienza R.S., Schultz L.R., and Johnson C.C. Oral contraceptive use may protect against low bone mass. Henry Ford Hospital Osteoporosis Cooperative Research Group. Arch Intern Med 151 (1991) 1971-1976
16. Gambacciani M., Spinetti A., Taponeco F., Cappagli B., Piaggesi L., and Fioretti P. Longitudinal evaluation of perimenopausal vertebral bone loss: effects of a low-dose oral contraceptive preparation on bone mineral density and metabolism. Obstet Gynecol 83 (1994) 392-396
17. Volpe A., Amram A., Cagnacci A., and Battaglia C. Biochemical aspects of hormonal contraception: effects on bone metabolism. Eur J Contracept Reprod Health Care 2 (1997) 123-126
18. Mazess R.B., and Barden H.S. Bone density in premenopausal women: effects of age, dietary intake, physical activity, smoking, and birth-control pills. Am J Clin Nutr 53 (1991) 132-142
19. Rodin A., Chapman M., and Fogelman I. Bone density in users of combined oral contraception: preliminary reports of a pilot study. Br J Fam Plann 16 (1991) 125-129
20. Murphy S., Khaw K.T., and Compston J.E. Lack of relationship between hip and spine bone mineral density and oral contraceptive use. Eur J Clin Invest 23 (1993) 108-111
21. Lloyd T., Buchanan J.R., Ursino G.R., Myers C., Woodward G., and Halbert D.R. Long-term oral contraceptive use does not affect trabecular bone mineral density. Am J Obstet Gynecol 160 (1989) 402-404
22. Tuppurainen M., Kroger H., Saarikoski S., Honkanen R., and Alhava E. The effect of previous oral contraceptive use on bone mineral density in perimenopausal women. Osteoporos Int 4 (1994) 93-98
23. Massai R., Mäkäräinen L., Kuukankorpi A., Klipping C., Duijkers I., and Dieben T. The combined contraceptive vaginal ring and bone mineral density in healthy pre-menopausal women. Hum Reprod 20 (2005) 2764-2768
24. Eyre D.R. New biomarkers of bone resorption. J Clin Endocrinol Metab 74 (1992) 470A-C
25. Jergas M., and Genant H.K. Lateral dual X-ray absorptiometry of the lumbar spine: current status. Bone 4 (1997) 311-314